nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—Topoisomerase Inhibitors—Epirubicin—uterine cancer	0.223	0.519	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Doxorubicin—uterine cancer	0.206	0.481	CiPCiCtD
Etoposide—muscle cancer—uterine cancer	0.102	0.371	CtDrD
Etoposide—germ cell cancer—uterine cancer	0.0916	0.333	CtDrD
Etoposide—sarcoma—uterine cancer	0.0813	0.296	CtDrD
Etoposide—GSTT1—Carboplatin—uterine cancer	0.0371	0.17	CbGbCtD
Etoposide—ABCC6—Dactinomycin—uterine cancer	0.0317	0.145	CbGbCtD
Etoposide—GSTP1—Carboplatin—uterine cancer	0.0232	0.106	CbGbCtD
Etoposide—TOP2A—Epirubicin—uterine cancer	0.0122	0.0559	CbGbCtD
Etoposide—ABCC6—Doxorubicin—uterine cancer	0.0122	0.0558	CbGbCtD
Etoposide—ABCC1—Progesterone—uterine cancer	0.0118	0.0539	CbGbCtD
Etoposide—ABCC1—Dactinomycin—uterine cancer	0.00934	0.0427	CbGbCtD
Etoposide—ABCC10—Doxorubicin—uterine cancer	0.00931	0.0426	CbGbCtD
Etoposide—ABCC1—Epirubicin—uterine cancer	0.00677	0.031	CbGbCtD
Etoposide—TOP2A—Doxorubicin—uterine cancer	0.00649	0.0297	CbGbCtD
Etoposide—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.00634	0.029	CbGbCtD
Etoposide—ABCG2—Dactinomycin—uterine cancer	0.00625	0.0286	CbGbCtD
Etoposide—ABCC3—Doxorubicin—uterine cancer	0.00586	0.0268	CbGbCtD
Etoposide—ABCC2—Carboplatin—uterine cancer	0.00465	0.0213	CbGbCtD
Etoposide—CYP3A5—Progesterone—uterine cancer	0.00437	0.02	CbGbCtD
Etoposide—ABCG2—Carboplatin—uterine cancer	0.0042	0.0192	CbGbCtD
Etoposide—CYP2C8—Progesterone—uterine cancer	0.0042	0.0192	CbGbCtD
Etoposide—ABCC1—Doxorubicin—uterine cancer	0.0036	0.0165	CbGbCtD
Etoposide—CYP1A2—Progesterone—uterine cancer	0.00325	0.0149	CbGbCtD
Etoposide—ABCB1—Progesterone—uterine cancer	0.00284	0.013	CbGbCtD
Etoposide—ABCC2—Doxorubicin—uterine cancer	0.00266	0.0122	CbGbCtD
Etoposide—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00257	0.0118	CbGbCtD
Etoposide—ABCG2—Doxorubicin—uterine cancer	0.00241	0.011	CbGbCtD
Etoposide—ABCB1—Dactinomycin—uterine cancer	0.00225	0.0103	CbGbCtD
Etoposide—CYP3A4—Progesterone—uterine cancer	0.0017	0.00779	CbGbCtD
Etoposide—GSTP1—oviduct—uterine cancer	0.000884	0.0417	CbGeAlD
Etoposide—ABCB1—Doxorubicin—uterine cancer	0.000868	0.00397	CbGbCtD
Etoposide—CYP3A4—Doxorubicin—uterine cancer	0.00052	0.00238	CbGbCtD
Etoposide—GSTP1—exocrine gland—uterine cancer	0.00051	0.024	CbGeAlD
Etoposide—TOP2B—myometrium—uterine cancer	0.000451	0.0213	CbGeAlD
Etoposide—GSTT1—renal system—uterine cancer	0.000446	0.021	CbGeAlD
Etoposide—PTGS1—oviduct—uterine cancer	0.000431	0.0203	CbGeAlD
Etoposide—ABCC6—renal system—uterine cancer	0.000362	0.0171	CbGeAlD
Etoposide—GSTT1—female reproductive system—uterine cancer	0.000357	0.0168	CbGeAlD
Etoposide—TOP2B—uterine cervix—uterine cancer	0.000351	0.0166	CbGeAlD
Etoposide—TOP2B—smooth muscle tissue—uterine cancer	0.000341	0.0161	CbGeAlD
Etoposide—TOP2B—decidua—uterine cancer	0.000335	0.0158	CbGeAlD
Etoposide—TOP2A—myometrium—uterine cancer	0.000332	0.0156	CbGeAlD
Etoposide—TOP2B—renal system—uterine cancer	0.000329	0.0155	CbGeAlD
Etoposide—TOP2B—endometrium—uterine cancer	0.000318	0.015	CbGeAlD
Etoposide—TOP2B—mammalian vulva—uterine cancer	0.000307	0.0145	CbGeAlD
Etoposide—TOP2B—uterus—uterine cancer	0.000293	0.0138	CbGeAlD
Etoposide—PTGS1—artery—uterine cancer	0.000286	0.0135	CbGeAlD
Etoposide—GSTP1—myometrium—uterine cancer	0.000283	0.0133	CbGeAlD
Etoposide—ABCC10—myometrium—uterine cancer	0.000283	0.0133	CbGeAlD
Etoposide—PTGS2—artery—uterine cancer	0.000273	0.0129	CbGeAlD
Etoposide—TOP2B—female reproductive system—uterine cancer	0.000263	0.0124	CbGeAlD
Etoposide—UGT1A1—renal system—uterine cancer	0.000262	0.0123	CbGeAlD
Etoposide—TOP2A—uterine cervix—uterine cancer	0.000258	0.0122	CbGeAlD
Etoposide—TOP2A—decidua—uterine cancer	0.000246	0.0116	CbGeAlD
Etoposide—TOP2B—female gonad—uterine cancer	0.000239	0.0113	CbGeAlD
Etoposide—TOP2B—vagina—uterine cancer	0.000238	0.0112	CbGeAlD
Etoposide—TOP2A—endometrium—uterine cancer	0.000234	0.011	CbGeAlD
Etoposide—TOP2A—mammalian vulva—uterine cancer	0.000226	0.0107	CbGeAlD
Etoposide—GSTP1—epithelium—uterine cancer	0.000222	0.0105	CbGeAlD
Etoposide—GSTP1—uterine cervix—uterine cancer	0.00022	0.0104	CbGeAlD
Etoposide—ABCC10—uterine cervix—uterine cancer	0.00022	0.0104	CbGeAlD
Etoposide—TOP2A—uterus—uterine cancer	0.000215	0.0101	CbGeAlD
Etoposide—GSTP1—smooth muscle tissue—uterine cancer	0.000214	0.0101	CbGeAlD
Etoposide—ABCC3—decidua—uterine cancer	0.000211	0.00992	CbGeAlD
Etoposide—GSTP1—decidua—uterine cancer	0.00021	0.00988	CbGeAlD
Etoposide—ABCC10—decidua—uterine cancer	0.00021	0.00988	CbGeAlD
Etoposide—ABCC3—renal system—uterine cancer	0.000207	0.00974	CbGeAlD
Etoposide—GSTP1—renal system—uterine cancer	0.000206	0.0097	CbGeAlD
Etoposide—ABCC10—renal system—uterine cancer	0.000206	0.0097	CbGeAlD
Etoposide—ABCC1—myometrium—uterine cancer	0.0002	0.00942	CbGeAlD
Etoposide—GSTP1—endometrium—uterine cancer	0.000199	0.00938	CbGeAlD
Etoposide—ABCC10—endometrium—uterine cancer	0.000199	0.00938	CbGeAlD
Etoposide—GSTP1—mammalian vulva—uterine cancer	0.000193	0.00907	CbGeAlD
Etoposide—ABCC10—mammalian vulva—uterine cancer	0.000192	0.00907	CbGeAlD
Etoposide—GSTP1—uterus—uterine cancer	0.000183	0.00864	CbGeAlD
Etoposide—ABCC10—uterus—uterine cancer	0.000183	0.00864	CbGeAlD
Etoposide—TOP2A—female gonad—uterine cancer	0.000176	0.0083	CbGeAlD
Etoposide—TOP2A—vagina—uterine cancer	0.000175	0.00825	CbGeAlD
Etoposide—ABCC3—female reproductive system—uterine cancer	0.000166	0.0078	CbGeAlD
Etoposide—ABCG2—myometrium—uterine cancer	0.000165	0.0078	CbGeAlD
Etoposide—ABCC2—renal system—uterine cancer	0.000165	0.00779	CbGeAlD
Etoposide—GSTP1—female reproductive system—uterine cancer	0.000165	0.00777	CbGeAlD
Etoposide—ABCC10—female reproductive system—uterine cancer	0.000165	0.00777	CbGeAlD
Etoposide—ABCC1—uterine cervix—uterine cancer	0.000156	0.00733	CbGeAlD
Etoposide—TOP2B—lymph node—uterine cancer	0.000154	0.00726	CbGeAlD
Etoposide—ABCC3—female gonad—uterine cancer	0.000151	0.0071	CbGeAlD
Etoposide—GSTP1—female gonad—uterine cancer	0.00015	0.00707	CbGeAlD
Etoposide—ABCC10—female gonad—uterine cancer	0.00015	0.00707	CbGeAlD
Etoposide—GSTP1—vagina—uterine cancer	0.000149	0.00703	CbGeAlD
Etoposide—ABCC10—vagina—uterine cancer	0.000149	0.00702	CbGeAlD
Etoposide—ABCC1—decidua—uterine cancer	0.000148	0.00699	CbGeAlD
Etoposide—ABCC1—endometrium—uterine cancer	0.000141	0.00663	CbGeAlD
Etoposide—ABCC1—mammalian vulva—uterine cancer	0.000136	0.00641	CbGeAlD
Etoposide—ABCC2—female reproductive system—uterine cancer	0.000132	0.00624	CbGeAlD
Etoposide—PTGS2—myometrium—uterine cancer	0.000132	0.00622	CbGeAlD
Etoposide—ABCC1—uterus—uterine cancer	0.00013	0.00611	CbGeAlD
Etoposide—ABCG2—uterine cervix—uterine cancer	0.000129	0.00607	CbGeAlD
Etoposide—CYP2C8—renal system—uterine cancer	0.000124	0.00584	CbGeAlD
Etoposide—ABCG2—decidua—uterine cancer	0.000123	0.00578	CbGeAlD
Etoposide—CYP2C8—endometrium—uterine cancer	0.00012	0.00565	CbGeAlD
Etoposide—CYP3A5—uterine cervix—uterine cancer	0.00012	0.00563	CbGeAlD
Etoposide—TOP2A—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	0.000117	0.152	CbGdCrCtD
Etoposide—ABCG2—endometrium—uterine cancer	0.000116	0.00549	CbGeAlD
Etoposide—CYP1A2—renal system—uterine cancer	0.000116	0.00546	CbGeAlD
Etoposide—TOP2A—lymph node—uterine cancer	0.000113	0.00534	CbGeAlD
Etoposide—ABCG2—mammalian vulva—uterine cancer	0.000113	0.00531	CbGeAlD
Etoposide—CYP3A5—renal system—uterine cancer	0.000112	0.00527	CbGeAlD
Etoposide—PTGS1—epithelium—uterine cancer	0.000108	0.00511	CbGeAlD
Etoposide—PTGS1—uterine cervix—uterine cancer	0.000107	0.00506	CbGeAlD
Etoposide—ABCG2—uterus—uterine cancer	0.000107	0.00506	CbGeAlD
Etoposide—ABCC1—female gonad—uterine cancer	0.000106	0.005	CbGeAlD
Etoposide—ABCC1—vagina—uterine cancer	0.000105	0.00497	CbGeAlD
Etoposide—PTGS1—smooth muscle tissue—uterine cancer	0.000104	0.00492	CbGeAlD
Etoposide—CYP2E1—renal system—uterine cancer	0.000104	0.00492	CbGeAlD
Etoposide—PTGS2—epithelium—uterine cancer	0.000104	0.00488	CbGeAlD
Etoposide—PTGS2—uterine cervix—uterine cancer	0.000103	0.00484	CbGeAlD
Etoposide—TOP2A—Methyltestosterone—Progesterone—uterine cancer	0.000102	0.132	CbGdCrCtD
Etoposide—PTGS1—renal system—uterine cancer	0.0001	0.00474	CbGeAlD
Etoposide—PTGS2—smooth muscle tissue—uterine cancer	9.98e-05	0.0047	CbGeAlD
Etoposide—CYP2C8—female reproductive system—uterine cancer	9.92e-05	0.00468	CbGeAlD
Etoposide—PTGS1—endometrium—uterine cancer	9.71e-05	0.00458	CbGeAlD
Etoposide—ABCC3—lymph node—uterine cancer	9.69e-05	0.00457	CbGeAlD
Etoposide—GSTP1—lymph node—uterine cancer	9.64e-05	0.00455	CbGeAlD
Etoposide—ABCC10—lymph node—uterine cancer	9.64e-05	0.00454	CbGeAlD
Etoposide—PTGS2—renal system—uterine cancer	9.6e-05	0.00453	CbGeAlD
Etoposide—PTGS1—mammalian vulva—uterine cancer	9.4e-05	0.00443	CbGeAlD
Etoposide—PTGS2—endometrium—uterine cancer	9.28e-05	0.00438	CbGeAlD
Etoposide—CYP2C8—vagina—uterine cancer	8.97e-05	0.00423	CbGeAlD
Etoposide—PTGS1—uterus—uterine cancer	8.95e-05	0.00422	CbGeAlD
Etoposide—ABCG2—female gonad—uterine cancer	8.78e-05	0.00414	CbGeAlD
Etoposide—ABCG2—vagina—uterine cancer	8.73e-05	0.00411	CbGeAlD
Etoposide—PTGS2—uterus—uterine cancer	8.56e-05	0.00403	CbGeAlD
Etoposide—CYP3A4—renal system—uterine cancer	8.39e-05	0.00396	CbGeAlD
Etoposide—CYP2E1—female reproductive system—uterine cancer	8.35e-05	0.00394	CbGeAlD
Etoposide—ABCB1—myometrium—uterine cancer	8.16e-05	0.00385	CbGeAlD
Etoposide—CYP3A5—female gonad—uterine cancer	8.15e-05	0.00384	CbGeAlD
Etoposide—CYP3A5—vagina—uterine cancer	8.1e-05	0.00382	CbGeAlD
Etoposide—PTGS1—female reproductive system—uterine cancer	8.05e-05	0.00379	CbGeAlD
Etoposide—ABCC2—lymph node—uterine cancer	7.74e-05	0.00365	CbGeAlD
Etoposide—PTGS2—female reproductive system—uterine cancer	7.69e-05	0.00363	CbGeAlD
Etoposide—TOP2A—Daunorubicin—Epirubicin—uterine cancer	7.47e-05	0.0971	CbGdCrCtD
Etoposide—TOP2A—Doxorubicin—Epirubicin—uterine cancer	7.47e-05	0.0971	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Epirubicin—uterine cancer	7.47e-05	0.0971	CbGdCrCtD
Etoposide—PTGS1—female gonad—uterine cancer	7.32e-05	0.00345	CbGeAlD
Etoposide—PTGS1—vagina—uterine cancer	7.28e-05	0.00343	CbGeAlD
Etoposide—Gastrointestinal disorder—Progesterone—uterine cancer	7.13e-05	0.00173	CcSEcCtD
Etoposide—Fatigue—Progesterone—uterine cancer	7.12e-05	0.00173	CcSEcCtD
Etoposide—Constipation—Progesterone—uterine cancer	7.06e-05	0.00171	CcSEcCtD
Etoposide—Pain—Progesterone—uterine cancer	7.06e-05	0.00171	CcSEcCtD
Etoposide—Extravasation—Doxorubicin—uterine cancer	7.04e-05	0.00171	CcSEcCtD
Etoposide—Ulcer—Epirubicin—uterine cancer	7.02e-05	0.0017	CcSEcCtD
Etoposide—PTGS2—female gonad—uterine cancer	7e-05	0.0033	CbGeAlD
Etoposide—Hypotension—Medroxyprogesterone Acetate—uterine cancer	6.99e-05	0.0017	CcSEcCtD
Etoposide—Cardiovascular disorder—Doxorubicin—uterine cancer	6.99e-05	0.0017	CcSEcCtD
Etoposide—PTGS2—vagina—uterine cancer	6.96e-05	0.00328	CbGeAlD
Etoposide—TOP2A—Epirubicin—Doxorubicin—uterine cancer	6.91e-05	0.0899	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Doxorubicin—uterine cancer	6.91e-05	0.0899	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Doxorubicin—uterine cancer	6.91e-05	0.0899	CbGdCrCtD
Etoposide—Inflammation—Epirubicin—uterine cancer	6.84e-05	0.00166	CcSEcCtD
Etoposide—ABCC1—lymph node—uterine cancer	6.82e-05	0.00321	CbGeAlD
Etoposide—Feeling abnormal—Progesterone—uterine cancer	6.81e-05	0.00165	CcSEcCtD
Etoposide—Skin discolouration—Doxorubicin—uterine cancer	6.8e-05	0.00165	CcSEcCtD
Etoposide—Blood uric acid increased—Epirubicin—uterine cancer	6.76e-05	0.00164	CcSEcCtD
Etoposide—Cellulitis—Doxorubicin—uterine cancer	6.75e-05	0.00164	CcSEcCtD
Etoposide—Gastrointestinal pain—Progesterone—uterine cancer	6.75e-05	0.00164	CcSEcCtD
Etoposide—CYP3A4—female reproductive system—uterine cancer	6.72e-05	0.00317	CbGeAlD
Etoposide—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	6.72e-05	0.00163	CcSEcCtD
Etoposide—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	6.67e-05	0.00162	CcSEcCtD
Etoposide—Somnolence—Medroxyprogesterone Acetate—uterine cancer	6.65e-05	0.00161	CcSEcCtD
Etoposide—TOP2A—Norethindrone—Progesterone—uterine cancer	6.64e-05	0.0863	CbGdCrCtD
Etoposide—Phosphatase alkaline increased—Epirubicin—uterine cancer	6.64e-05	0.00161	CcSEcCtD
Etoposide—Ill-defined disorder—Dactinomycin—uterine cancer	6.64e-05	0.00161	CcSEcCtD
Etoposide—Hyperuricaemia—Doxorubicin—uterine cancer	6.62e-05	0.00161	CcSEcCtD
Etoposide—Anaemia—Dactinomycin—uterine cancer	6.61e-05	0.0016	CcSEcCtD
Etoposide—Urticaria—Progesterone—uterine cancer	6.56e-05	0.00159	CcSEcCtD
Etoposide—Abdominal pain—Progesterone—uterine cancer	6.53e-05	0.00158	CcSEcCtD
Etoposide—Body temperature increased—Progesterone—uterine cancer	6.53e-05	0.00158	CcSEcCtD
Etoposide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	6.5e-05	0.00158	CcSEcCtD
Etoposide—Ulcer—Doxorubicin—uterine cancer	6.49e-05	0.00158	CcSEcCtD
Etoposide—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	6.46e-05	0.00157	CcSEcCtD
Etoposide—Fatigue—Medroxyprogesterone Acetate—uterine cancer	6.45e-05	0.00157	CcSEcCtD
Etoposide—Malaise—Dactinomycin—uterine cancer	6.45e-05	0.00157	CcSEcCtD
Etoposide—ABCB1—epithelium—uterine cancer	6.4e-05	0.00302	CbGeAlD
Etoposide—Leukopenia—Dactinomycin—uterine cancer	6.4e-05	0.00155	CcSEcCtD
Etoposide—Constipation—Medroxyprogesterone Acetate—uterine cancer	6.4e-05	0.00155	CcSEcCtD
Etoposide—ABCB1—uterine cervix—uterine cancer	6.35e-05	0.00299	CbGeAlD
Etoposide—Candida infection—Epirubicin—uterine cancer	6.34e-05	0.00154	CcSEcCtD
Etoposide—Skin exfoliation—Epirubicin—uterine cancer	6.34e-05	0.00154	CcSEcCtD
Etoposide—Inflammation—Doxorubicin—uterine cancer	6.33e-05	0.00154	CcSEcCtD
Etoposide—Blood uric acid increased—Doxorubicin—uterine cancer	6.25e-05	0.00152	CcSEcCtD
Etoposide—Neuropathy—Epirubicin—uterine cancer	6.23e-05	0.00151	CcSEcCtD
Etoposide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	6.17e-05	0.0015	CcSEcCtD
Etoposide—Phosphatase alkaline increased—Doxorubicin—uterine cancer	6.14e-05	0.00149	CcSEcCtD
Etoposide—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	6.12e-05	0.00149	CcSEcCtD
Etoposide—Hypersensitivity—Progesterone—uterine cancer	6.08e-05	0.00148	CcSEcCtD
Etoposide—Oesophagitis—Epirubicin—uterine cancer	6.06e-05	0.00147	CcSEcCtD
Etoposide—ABCB1—decidua—uterine cancer	6.05e-05	0.00285	CbGeAlD
Etoposide—Rash maculo-papular—Epirubicin—uterine cancer	6.03e-05	0.00146	CcSEcCtD
Etoposide—Discomfort—Dactinomycin—uterine cancer	6.02e-05	0.00146	CcSEcCtD
Etoposide—Mouth ulceration—Epirubicin—uterine cancer	6e-05	0.00146	CcSEcCtD
Etoposide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	5.94e-05	0.00144	CcSEcCtD
Etoposide—ABCB1—renal system—uterine cancer	5.94e-05	0.0028	CbGeAlD
Etoposide—Asthenia—Progesterone—uterine cancer	5.92e-05	0.00144	CcSEcCtD
Etoposide—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	5.92e-05	0.00144	CcSEcCtD
Etoposide—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	5.92e-05	0.00144	CcSEcCtD
Etoposide—Skin exfoliation—Doxorubicin—uterine cancer	5.86e-05	0.00142	CcSEcCtD
Etoposide—Candida infection—Doxorubicin—uterine cancer	5.86e-05	0.00142	CcSEcCtD
Etoposide—Pruritus—Progesterone—uterine cancer	5.84e-05	0.00142	CcSEcCtD
Etoposide—Infection—Dactinomycin—uterine cancer	5.8e-05	0.00141	CcSEcCtD
Etoposide—Neuropathy—Doxorubicin—uterine cancer	5.77e-05	0.0014	CcSEcCtD
Etoposide—Sepsis—Epirubicin—uterine cancer	5.76e-05	0.0014	CcSEcCtD
Etoposide—ABCB1—endometrium—uterine cancer	5.74e-05	0.00271	CbGeAlD
Etoposide—Thrombocytopenia—Dactinomycin—uterine cancer	5.71e-05	0.00139	CcSEcCtD
Etoposide—Diarrhoea—Progesterone—uterine cancer	5.65e-05	0.00137	CcSEcCtD
Etoposide—ABCG2—lymph node—uterine cancer	5.64e-05	0.00266	CbGeAlD
Etoposide—Oesophagitis—Doxorubicin—uterine cancer	5.61e-05	0.00136	CcSEcCtD
Etoposide—Phlebitis—Epirubicin—uterine cancer	5.59e-05	0.00136	CcSEcCtD
Etoposide—Rash maculo-papular—Doxorubicin—uterine cancer	5.58e-05	0.00135	CcSEcCtD
Etoposide—Anorexia—Dactinomycin—uterine cancer	5.56e-05	0.00135	CcSEcCtD
Etoposide—ABCB1—mammalian vulva—uterine cancer	5.56e-05	0.00262	CbGeAlD
Etoposide—Mouth ulceration—Doxorubicin—uterine cancer	5.55e-05	0.00135	CcSEcCtD
Etoposide—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	5.54e-05	0.00134	CcSEcCtD
Etoposide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	5.51e-05	0.00134	CcSEcCtD
Etoposide—Dizziness—Progesterone—uterine cancer	5.46e-05	0.00133	CcSEcCtD
Etoposide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	5.37e-05	0.0013	CcSEcCtD
Etoposide—Sepsis—Doxorubicin—uterine cancer	5.33e-05	0.00129	CcSEcCtD
Etoposide—Cardiac failure congestive—Epirubicin—uterine cancer	5.31e-05	0.00129	CcSEcCtD
Etoposide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	5.29e-05	0.00129	CcSEcCtD
Etoposide—ABCB1—uterus—uterine cancer	5.29e-05	0.00249	CbGeAlD
Etoposide—TOP2A—Levonorgestrel—Progesterone—uterine cancer	5.29e-05	0.0687	CbGdCrCtD
Etoposide—Vomiting—Progesterone—uterine cancer	5.25e-05	0.00127	CcSEcCtD
Etoposide—Rash—Progesterone—uterine cancer	5.21e-05	0.00126	CcSEcCtD
Etoposide—Dermatitis—Progesterone—uterine cancer	5.2e-05	0.00126	CcSEcCtD
Etoposide—Phlebitis—Doxorubicin—uterine cancer	5.17e-05	0.00126	CcSEcCtD
Etoposide—Headache—Progesterone—uterine cancer	5.17e-05	0.00126	CcSEcCtD
Etoposide—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	5.13e-05	0.00124	CcSEcCtD
Etoposide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	5.12e-05	0.00124	CcSEcCtD
Etoposide—Decreased appetite—Dactinomycin—uterine cancer	5.07e-05	0.00123	CcSEcCtD
Etoposide—Fatigue—Dactinomycin—uterine cancer	5.03e-05	0.00122	CcSEcCtD
Etoposide—Pain—Dactinomycin—uterine cancer	4.99e-05	0.00121	CcSEcCtD
Etoposide—Anaphylactoid reaction—Epirubicin—uterine cancer	4.98e-05	0.00121	CcSEcCtD
Etoposide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	4.95e-05	0.0012	CcSEcCtD
Etoposide—Cardiac failure—Epirubicin—uterine cancer	4.94e-05	0.0012	CcSEcCtD
Etoposide—Cardiac failure congestive—Doxorubicin—uterine cancer	4.92e-05	0.00119	CcSEcCtD
Etoposide—Nausea—Progesterone—uterine cancer	4.91e-05	0.00119	CcSEcCtD
Etoposide—Feeling abnormal—Dactinomycin—uterine cancer	4.81e-05	0.00117	CcSEcCtD
Etoposide—Gastrointestinal pain—Dactinomycin—uterine cancer	4.77e-05	0.00116	CcSEcCtD
Etoposide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	4.76e-05	0.00115	CcSEcCtD
Etoposide—ABCB1—female reproductive system—uterine cancer	4.76e-05	0.00224	CbGeAlD
Etoposide—Rash—Medroxyprogesterone Acetate—uterine cancer	4.72e-05	0.00115	CcSEcCtD
Etoposide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	4.71e-05	0.00114	CcSEcCtD
Etoposide—PTGS1—lymph node—uterine cancer	4.71e-05	0.00222	CbGeAlD
Etoposide—Headache—Medroxyprogesterone Acetate—uterine cancer	4.69e-05	0.00114	CcSEcCtD
Etoposide—Body temperature increased—Dactinomycin—uterine cancer	4.61e-05	0.00112	CcSEcCtD
Etoposide—Abdominal pain—Dactinomycin—uterine cancer	4.61e-05	0.00112	CcSEcCtD
Etoposide—Anaphylactoid reaction—Doxorubicin—uterine cancer	4.61e-05	0.00112	CcSEcCtD
Etoposide—Cardiac arrest—Epirubicin—uterine cancer	4.58e-05	0.00111	CcSEcCtD
Etoposide—Cardiac failure—Doxorubicin—uterine cancer	4.57e-05	0.00111	CcSEcCtD
Etoposide—PTGS2—lymph node—uterine cancer	4.5e-05	0.00212	CbGeAlD
Etoposide—Nausea—Medroxyprogesterone Acetate—uterine cancer	4.44e-05	0.00108	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Epirubicin—uterine cancer	4.34e-05	0.00105	CcSEcCtD
Etoposide—ABCB1—female gonad—uterine cancer	4.33e-05	0.00204	CbGeAlD
Etoposide—ABCB1—vagina—uterine cancer	4.3e-05	0.00203	CbGeAlD
Etoposide—Hypersensitivity—Dactinomycin—uterine cancer	4.3e-05	0.00104	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Epirubicin—uterine cancer	4.25e-05	0.00103	CcSEcCtD
Etoposide—Cardiac arrest—Doxorubicin—uterine cancer	4.24e-05	0.00103	CcSEcCtD
Etoposide—Asthenia—Dactinomycin—uterine cancer	4.19e-05	0.00102	CcSEcCtD
Etoposide—Dysphagia—Epirubicin—uterine cancer	4.16e-05	0.00101	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	4.01e-05	0.000974	CcSEcCtD
Etoposide—Diarrhoea—Dactinomycin—uterine cancer	3.99e-05	0.000969	CcSEcCtD
Etoposide—Pancytopenia—Epirubicin—uterine cancer	3.95e-05	0.00096	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Doxorubicin—uterine cancer	3.93e-05	0.000954	CcSEcCtD
Etoposide—Neutropenia—Epirubicin—uterine cancer	3.89e-05	0.000945	CcSEcCtD
Etoposide—Dysphagia—Doxorubicin—uterine cancer	3.85e-05	0.000935	CcSEcCtD
Etoposide—Pneumonia—Epirubicin—uterine cancer	3.73e-05	0.000906	CcSEcCtD
Etoposide—Infestation—Epirubicin—uterine cancer	3.71e-05	0.000901	CcSEcCtD
Etoposide—Infestation NOS—Epirubicin—uterine cancer	3.71e-05	0.000901	CcSEcCtD
Etoposide—Vomiting—Dactinomycin—uterine cancer	3.71e-05	0.000901	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Epirubicin—uterine cancer	3.68e-05	0.000893	CcSEcCtD
Etoposide—Rash—Dactinomycin—uterine cancer	3.68e-05	0.000893	CcSEcCtD
Etoposide—Pancytopenia—Doxorubicin—uterine cancer	3.66e-05	0.000888	CcSEcCtD
Etoposide—Renal failure—Epirubicin—uterine cancer	3.65e-05	0.000886	CcSEcCtD
Etoposide—Neuropathy peripheral—Epirubicin—uterine cancer	3.64e-05	0.000883	CcSEcCtD
Etoposide—Jaundice—Epirubicin—uterine cancer	3.62e-05	0.000878	CcSEcCtD
Etoposide—Stomatitis—Epirubicin—uterine cancer	3.62e-05	0.000878	CcSEcCtD
Etoposide—Neutropenia—Doxorubicin—uterine cancer	3.6e-05	0.000875	CcSEcCtD
Etoposide—Hepatobiliary disease—Epirubicin—uterine cancer	3.51e-05	0.000852	CcSEcCtD
Etoposide—Nausea—Dactinomycin—uterine cancer	3.47e-05	0.000842	CcSEcCtD
Etoposide—Agranulocytosis—Epirubicin—uterine cancer	3.46e-05	0.000841	CcSEcCtD
Etoposide—Pneumonia—Doxorubicin—uterine cancer	3.46e-05	0.000839	CcSEcCtD
Etoposide—Infestation NOS—Doxorubicin—uterine cancer	3.44e-05	0.000834	CcSEcCtD
Etoposide—Infestation—Doxorubicin—uterine cancer	3.44e-05	0.000834	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	3.41e-05	0.000827	CcSEcCtD
Etoposide—Renal failure—Doxorubicin—uterine cancer	3.38e-05	0.00082	CcSEcCtD
Etoposide—Neuropathy peripheral—Doxorubicin—uterine cancer	3.37e-05	0.000817	CcSEcCtD
Etoposide—Stomatitis—Doxorubicin—uterine cancer	3.35e-05	0.000813	CcSEcCtD
Etoposide—Jaundice—Doxorubicin—uterine cancer	3.35e-05	0.000813	CcSEcCtD
Etoposide—Hypoaesthesia—Epirubicin—uterine cancer	3.32e-05	0.000805	CcSEcCtD
Etoposide—Urinary tract disorder—Epirubicin—uterine cancer	3.29e-05	0.000799	CcSEcCtD
Etoposide—Urethral disorder—Epirubicin—uterine cancer	3.27e-05	0.000793	CcSEcCtD
Etoposide—Hepatobiliary disease—Doxorubicin—uterine cancer	3.25e-05	0.000789	CcSEcCtD
Etoposide—Agranulocytosis—Doxorubicin—uterine cancer	3.21e-05	0.000778	CcSEcCtD
Etoposide—Erythema multiforme—Epirubicin—uterine cancer	3.15e-05	0.000765	CcSEcCtD
Etoposide—Eye disorder—Epirubicin—uterine cancer	3.11e-05	0.000756	CcSEcCtD
Etoposide—Flushing—Epirubicin—uterine cancer	3.09e-05	0.000751	CcSEcCtD
Etoposide—Cardiac disorder—Epirubicin—uterine cancer	3.09e-05	0.000751	CcSEcCtD
Etoposide—Hypoaesthesia—Doxorubicin—uterine cancer	3.07e-05	0.000745	CcSEcCtD
Etoposide—Urinary tract disorder—Doxorubicin—uterine cancer	3.05e-05	0.000739	CcSEcCtD
Etoposide—Angiopathy—Epirubicin—uterine cancer	3.02e-05	0.000734	CcSEcCtD
Etoposide—Urethral disorder—Doxorubicin—uterine cancer	3.02e-05	0.000734	CcSEcCtD
Etoposide—Immune system disorder—Epirubicin—uterine cancer	3.01e-05	0.000731	CcSEcCtD
Etoposide—Mediastinal disorder—Epirubicin—uterine cancer	3e-05	0.000729	CcSEcCtD
Etoposide—Chills—Epirubicin—uterine cancer	2.99e-05	0.000726	CcSEcCtD
Etoposide—Alopecia—Epirubicin—uterine cancer	2.95e-05	0.000715	CcSEcCtD
Etoposide—Erythema multiforme—Doxorubicin—uterine cancer	2.92e-05	0.000708	CcSEcCtD
Etoposide—Eye disorder—Doxorubicin—uterine cancer	2.88e-05	0.0007	CcSEcCtD
Etoposide—Flushing—Doxorubicin—uterine cancer	2.86e-05	0.000695	CcSEcCtD
Etoposide—Cardiac disorder—Doxorubicin—uterine cancer	2.86e-05	0.000695	CcSEcCtD
Etoposide—Dysgeusia—Epirubicin—uterine cancer	2.84e-05	0.00069	CcSEcCtD
Etoposide—Back pain—Epirubicin—uterine cancer	2.81e-05	0.000681	CcSEcCtD
Etoposide—Angiopathy—Doxorubicin—uterine cancer	2.8e-05	0.000679	CcSEcCtD
Etoposide—Muscle spasms—Epirubicin—uterine cancer	2.79e-05	0.000677	CcSEcCtD
Etoposide—Immune system disorder—Doxorubicin—uterine cancer	2.79e-05	0.000676	CcSEcCtD
Etoposide—ABCB1—lymph node—uterine cancer	2.78e-05	0.00131	CbGeAlD
Etoposide—Mediastinal disorder—Doxorubicin—uterine cancer	2.78e-05	0.000675	CcSEcCtD
Etoposide—Chills—Doxorubicin—uterine cancer	2.77e-05	0.000672	CcSEcCtD
Etoposide—Alopecia—Doxorubicin—uterine cancer	2.73e-05	0.000661	CcSEcCtD
Etoposide—Ill-defined disorder—Epirubicin—uterine cancer	2.69e-05	0.000653	CcSEcCtD
Etoposide—Anaemia—Epirubicin—uterine cancer	2.68e-05	0.000651	CcSEcCtD
Etoposide—Dysgeusia—Doxorubicin—uterine cancer	2.63e-05	0.000638	CcSEcCtD
Etoposide—Malaise—Epirubicin—uterine cancer	2.62e-05	0.000635	CcSEcCtD
Etoposide—Vertigo—Epirubicin—uterine cancer	2.61e-05	0.000633	CcSEcCtD
Etoposide—Leukopenia—Epirubicin—uterine cancer	2.6e-05	0.00063	CcSEcCtD
Etoposide—Back pain—Doxorubicin—uterine cancer	2.6e-05	0.00063	CcSEcCtD
Etoposide—Muscle spasms—Doxorubicin—uterine cancer	2.58e-05	0.000626	CcSEcCtD
Etoposide—Loss of consciousness—Epirubicin—uterine cancer	2.55e-05	0.000619	CcSEcCtD
Etoposide—Cough—Epirubicin—uterine cancer	2.53e-05	0.000615	CcSEcCtD
Etoposide—Convulsion—Epirubicin—uterine cancer	2.51e-05	0.00061	CcSEcCtD
Etoposide—Hypertension—Epirubicin—uterine cancer	2.51e-05	0.000608	CcSEcCtD
Etoposide—Ill-defined disorder—Doxorubicin—uterine cancer	2.49e-05	0.000605	CcSEcCtD
Etoposide—Anaemia—Doxorubicin—uterine cancer	2.48e-05	0.000602	CcSEcCtD
Etoposide—Chest pain—Epirubicin—uterine cancer	2.47e-05	0.0006	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	2.45e-05	0.000595	CcSEcCtD
Etoposide—Discomfort—Epirubicin—uterine cancer	2.44e-05	0.000592	CcSEcCtD
Etoposide—Malaise—Doxorubicin—uterine cancer	2.42e-05	0.000588	CcSEcCtD
Etoposide—Vertigo—Doxorubicin—uterine cancer	2.41e-05	0.000585	CcSEcCtD
Etoposide—Leukopenia—Doxorubicin—uterine cancer	2.4e-05	0.000583	CcSEcCtD
Etoposide—Confusional state—Epirubicin—uterine cancer	2.39e-05	0.00058	CcSEcCtD
Etoposide—Anaphylactic shock—Epirubicin—uterine cancer	2.37e-05	0.000575	CcSEcCtD
Etoposide—Loss of consciousness—Doxorubicin—uterine cancer	2.36e-05	0.000573	CcSEcCtD
Etoposide—Infection—Epirubicin—uterine cancer	2.35e-05	0.000571	CcSEcCtD
Etoposide—Cough—Doxorubicin—uterine cancer	2.34e-05	0.000569	CcSEcCtD
Etoposide—Convulsion—Doxorubicin—uterine cancer	2.33e-05	0.000565	CcSEcCtD
Etoposide—Thrombocytopenia—Epirubicin—uterine cancer	2.32e-05	0.000563	CcSEcCtD
Etoposide—Hypertension—Doxorubicin—uterine cancer	2.32e-05	0.000563	CcSEcCtD
Etoposide—Tachycardia—Epirubicin—uterine cancer	2.31e-05	0.000561	CcSEcCtD
Etoposide—Skin disorder—Epirubicin—uterine cancer	2.3e-05	0.000558	CcSEcCtD
Etoposide—Hyperhidrosis—Epirubicin—uterine cancer	2.29e-05	0.000556	CcSEcCtD
Etoposide—Chest pain—Doxorubicin—uterine cancer	2.29e-05	0.000555	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	2.27e-05	0.000551	CcSEcCtD
Etoposide—Discomfort—Doxorubicin—uterine cancer	2.26e-05	0.000548	CcSEcCtD
Etoposide—Anorexia—Epirubicin—uterine cancer	2.26e-05	0.000548	CcSEcCtD
Etoposide—Hypotension—Epirubicin—uterine cancer	2.21e-05	0.000537	CcSEcCtD
Etoposide—Confusional state—Doxorubicin—uterine cancer	2.21e-05	0.000536	CcSEcCtD
Etoposide—Anaphylactic shock—Doxorubicin—uterine cancer	2.19e-05	0.000532	CcSEcCtD
Etoposide—Infection—Doxorubicin—uterine cancer	2.18e-05	0.000528	CcSEcCtD
Etoposide—Thrombocytopenia—Doxorubicin—uterine cancer	2.15e-05	0.000521	CcSEcCtD
Etoposide—Tachycardia—Doxorubicin—uterine cancer	2.14e-05	0.000519	CcSEcCtD
Etoposide—Skin disorder—Doxorubicin—uterine cancer	2.13e-05	0.000517	CcSEcCtD
Etoposide—Paraesthesia—Epirubicin—uterine cancer	2.13e-05	0.000516	CcSEcCtD
Etoposide—Hyperhidrosis—Doxorubicin—uterine cancer	2.12e-05	0.000514	CcSEcCtD
Etoposide—Dyspnoea—Epirubicin—uterine cancer	2.11e-05	0.000512	CcSEcCtD
Etoposide—Somnolence—Epirubicin—uterine cancer	2.11e-05	0.000511	CcSEcCtD
Etoposide—Anorexia—Doxorubicin—uterine cancer	2.09e-05	0.000507	CcSEcCtD
Etoposide—Decreased appetite—Epirubicin—uterine cancer	2.06e-05	0.0005	CcSEcCtD
Etoposide—Hypotension—Doxorubicin—uterine cancer	2.05e-05	0.000497	CcSEcCtD
Etoposide—Gastrointestinal disorder—Epirubicin—uterine cancer	2.04e-05	0.000496	CcSEcCtD
Etoposide—Fatigue—Epirubicin—uterine cancer	2.04e-05	0.000496	CcSEcCtD
Etoposide—Pain—Epirubicin—uterine cancer	2.02e-05	0.000492	CcSEcCtD
Etoposide—Constipation—Epirubicin—uterine cancer	2.02e-05	0.000492	CcSEcCtD
Etoposide—Paraesthesia—Doxorubicin—uterine cancer	1.97e-05	0.000478	CcSEcCtD
Etoposide—Dyspnoea—Doxorubicin—uterine cancer	1.95e-05	0.000474	CcSEcCtD
Etoposide—Feeling abnormal—Epirubicin—uterine cancer	1.95e-05	0.000474	CcSEcCtD
Etoposide—Somnolence—Doxorubicin—uterine cancer	1.95e-05	0.000473	CcSEcCtD
Etoposide—Gastrointestinal pain—Epirubicin—uterine cancer	1.94e-05	0.00047	CcSEcCtD
Etoposide—Decreased appetite—Doxorubicin—uterine cancer	1.9e-05	0.000462	CcSEcCtD
Etoposide—Gastrointestinal disorder—Doxorubicin—uterine cancer	1.89e-05	0.000459	CcSEcCtD
Etoposide—Fatigue—Doxorubicin—uterine cancer	1.89e-05	0.000459	CcSEcCtD
Etoposide—Urticaria—Epirubicin—uterine cancer	1.88e-05	0.000457	CcSEcCtD
Etoposide—Pain—Doxorubicin—uterine cancer	1.87e-05	0.000455	CcSEcCtD
Etoposide—Constipation—Doxorubicin—uterine cancer	1.87e-05	0.000455	CcSEcCtD
Etoposide—Body temperature increased—Epirubicin—uterine cancer	1.87e-05	0.000454	CcSEcCtD
Etoposide—Abdominal pain—Epirubicin—uterine cancer	1.87e-05	0.000454	CcSEcCtD
Etoposide—Feeling abnormal—Doxorubicin—uterine cancer	1.81e-05	0.000438	CcSEcCtD
Etoposide—Gastrointestinal pain—Doxorubicin—uterine cancer	1.79e-05	0.000435	CcSEcCtD
Etoposide—Hypersensitivity—Epirubicin—uterine cancer	1.74e-05	0.000423	CcSEcCtD
Etoposide—Urticaria—Doxorubicin—uterine cancer	1.74e-05	0.000422	CcSEcCtD
Etoposide—Abdominal pain—Doxorubicin—uterine cancer	1.73e-05	0.00042	CcSEcCtD
Etoposide—Body temperature increased—Doxorubicin—uterine cancer	1.73e-05	0.00042	CcSEcCtD
Etoposide—Asthenia—Epirubicin—uterine cancer	1.7e-05	0.000412	CcSEcCtD
Etoposide—Pruritus—Epirubicin—uterine cancer	1.68e-05	0.000407	CcSEcCtD
Etoposide—Diarrhoea—Epirubicin—uterine cancer	1.62e-05	0.000393	CcSEcCtD
Etoposide—Hypersensitivity—Doxorubicin—uterine cancer	1.61e-05	0.000392	CcSEcCtD
Etoposide—Asthenia—Doxorubicin—uterine cancer	1.57e-05	0.000382	CcSEcCtD
Etoposide—Dizziness—Epirubicin—uterine cancer	1.57e-05	0.00038	CcSEcCtD
Etoposide—Pruritus—Doxorubicin—uterine cancer	1.55e-05	0.000376	CcSEcCtD
Etoposide—Vomiting—Epirubicin—uterine cancer	1.51e-05	0.000365	CcSEcCtD
Etoposide—Diarrhoea—Doxorubicin—uterine cancer	1.5e-05	0.000364	CcSEcCtD
Etoposide—Rash—Epirubicin—uterine cancer	1.49e-05	0.000362	CcSEcCtD
Etoposide—Dermatitis—Epirubicin—uterine cancer	1.49e-05	0.000362	CcSEcCtD
Etoposide—Headache—Epirubicin—uterine cancer	1.48e-05	0.00036	CcSEcCtD
Etoposide—Dizziness—Doxorubicin—uterine cancer	1.45e-05	0.000352	CcSEcCtD
Etoposide—Nausea—Epirubicin—uterine cancer	1.41e-05	0.000341	CcSEcCtD
Etoposide—Vomiting—Doxorubicin—uterine cancer	1.39e-05	0.000338	CcSEcCtD
Etoposide—Rash—Doxorubicin—uterine cancer	1.38e-05	0.000335	CcSEcCtD
Etoposide—Dermatitis—Doxorubicin—uterine cancer	1.38e-05	0.000335	CcSEcCtD
Etoposide—Headache—Doxorubicin—uterine cancer	1.37e-05	0.000333	CcSEcCtD
Etoposide—Nausea—Doxorubicin—uterine cancer	1.3e-05	0.000316	CcSEcCtD
Etoposide—PTGS2—Spinal Cord Injury—TP53—uterine cancer	5.94e-06	0.000431	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	5.92e-06	0.00043	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—POLD1—uterine cancer	5.91e-06	0.000429	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.91e-06	0.000429	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—EP300—uterine cancer	5.9e-06	0.000428	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—EP300—uterine cancer	5.88e-06	0.000427	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—DCN—uterine cancer	5.87e-06	0.000426	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—SRD5A2—uterine cancer	5.87e-06	0.000426	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—NDUFB11—uterine cancer	5.87e-06	0.000426	CbGpPWpGaD
Etoposide—ABCC1—Disease—HMGA1—uterine cancer	5.86e-06	0.000425	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—RRM2—uterine cancer	5.83e-06	0.000423	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—AKR1C1—uterine cancer	5.76e-06	0.000418	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—DCN—uterine cancer	5.66e-06	0.000411	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	5.66e-06	0.000411	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	5.65e-06	0.00041	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AKR1B1—uterine cancer	5.63e-06	0.000409	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—STAR—uterine cancer	5.63e-06	0.000409	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AKR1B1—uterine cancer	5.62e-06	0.000408	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—STAR—uterine cancer	5.62e-06	0.000408	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.58e-06	0.000405	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—CYP11A1—uterine cancer	5.53e-06	0.000401	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—AKR1C1—uterine cancer	5.53e-06	0.000401	CbGpPWpGaD
Etoposide—ABCC1—Disease—FBXW7—uterine cancer	5.36e-06	0.000389	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	5.35e-06	0.000388	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—CYP11A1—uterine cancer	5.33e-06	0.000387	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—EP300—uterine cancer	5.26e-06	0.000382	CbGpPWpGaD
Etoposide—PTGS2—Disease—AKR1C1—uterine cancer	5.24e-06	0.00038	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—AKR1C3—uterine cancer	5.22e-06	0.000379	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—RRM2—uterine cancer	5.13e-06	0.000372	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—AKR1C3—uterine cancer	5.04e-06	0.000365	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—CYP19A1—uterine cancer	5.01e-06	0.000363	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—STK11—uterine cancer	5.01e-06	0.000363	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—DCN—uterine cancer	4.98e-06	0.000361	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—RRM2—uterine cancer	4.93e-06	0.000358	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	4.92e-06	0.000357	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—STAR—uterine cancer	4.87e-06	0.000353	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AKR1B1—uterine cancer	4.87e-06	0.000353	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.81e-06	0.000349	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—DCN—uterine cancer	4.79e-06	0.000347	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.7e-06	0.000341	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—POLD1—uterine cancer	4.69e-06	0.000341	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CYP11A1—uterine cancer	4.69e-06	0.000341	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—SRD5A2—uterine cancer	4.68e-06	0.00034	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—NDUFB11—uterine cancer	4.68e-06	0.00034	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	4.56e-06	0.000331	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.55e-06	0.00033	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	4.55e-06	0.00033	CbGpPWpGaD
Etoposide—PTGS2—Disease—DCN—uterine cancer	4.54e-06	0.000329	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CYP11A1—uterine cancer	4.51e-06	0.000327	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.48e-06	0.000325	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—AKR1C3—uterine cancer	4.43e-06	0.000322	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—POLD1—uterine cancer	4.42e-06	0.000321	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—POLD1—uterine cancer	4.41e-06	0.00032	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—AKR1C1—uterine cancer	4.39e-06	0.000319	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—PIK3CA—uterine cancer	4.36e-06	0.000317	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	4.31e-06	0.000312	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.3e-06	0.000312	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—AKR1C3—uterine cancer	4.26e-06	0.000309	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AKR1B1—uterine cancer	4.24e-06	0.000308	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—STAR—uterine cancer	4.24e-06	0.000308	CbGpPWpGaD
Etoposide—ABCC1—Disease—CDKN2B—uterine cancer	4.2e-06	0.000305	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	4.2e-06	0.000305	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	4.18e-06	0.000303	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AKR1C1—uterine cancer	4.13e-06	0.0003	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AKR1C1—uterine cancer	4.13e-06	0.000299	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—CYP19A1—uterine cancer	4.07e-06	0.000295	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—STK11—uterine cancer	4.07e-06	0.000295	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	4.04e-06	0.000293	CbGpPWpGaD
Etoposide—PTGS2—Disease—AKR1C3—uterine cancer	4.04e-06	0.000293	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	4e-06	0.00029	CbGpPWpGaD
Etoposide—PTGS2—Disease—HMGA1—uterine cancer	3.93e-06	0.000285	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—STK11—uterine cancer	3.92e-06	0.000285	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—CYP19A1—uterine cancer	3.92e-06	0.000285	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—RRM2—uterine cancer	3.91e-06	0.000284	CbGpPWpGaD
Etoposide—ABCC1—Disease—SMAD3—uterine cancer	3.84e-06	0.000278	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—POLD1—uterine cancer	3.82e-06	0.000277	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—DCN—uterine cancer	3.8e-06	0.000276	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	3.79e-06	0.000275	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—TP53—uterine cancer	3.77e-06	0.000273	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—MTHFR—uterine cancer	3.76e-06	0.000273	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—RRM2—uterine cancer	3.68e-06	0.000267	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.68e-06	0.000267	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—RRM2—uterine cancer	3.68e-06	0.000267	CbGpPWpGaD
Etoposide—ABCC1—Disease—FGFR2—uterine cancer	3.66e-06	0.000265	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—NDUFB11—uterine cancer	3.61e-06	0.000262	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—SRD5A2—uterine cancer	3.61e-06	0.000262	CbGpPWpGaD
Etoposide—PTGS2—Disease—FBXW7—uterine cancer	3.6e-06	0.000261	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CYP11A1—uterine cancer	3.58e-06	0.00026	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—DCN—uterine cancer	3.58e-06	0.00026	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AKR1C1—uterine cancer	3.57e-06	0.000259	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—DCN—uterine cancer	3.57e-06	0.000259	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—AKT1—uterine cancer	3.56e-06	0.000259	CbGpPWpGaD
Etoposide—ABCC1—Disease—MTHFR—uterine cancer	3.52e-06	0.000256	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.51e-06	0.000255	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—STK11—uterine cancer	3.45e-06	0.000251	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—CYP19A1—uterine cancer	3.45e-06	0.000251	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	3.41e-06	0.000248	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PTEN—uterine cancer	3.39e-06	0.000246	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AKR1B1—uterine cancer	3.39e-06	0.000246	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—STAR—uterine cancer	3.39e-06	0.000246	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—AKR1C3—uterine cancer	3.38e-06	0.000245	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CYP11A1—uterine cancer	3.37e-06	0.000245	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYP11A1—uterine cancer	3.36e-06	0.000244	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.35e-06	0.000243	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—POLD1—uterine cancer	3.33e-06	0.000241	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—STK11—uterine cancer	3.32e-06	0.000241	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—CYP19A1—uterine cancer	3.32e-06	0.000241	CbGpPWpGaD
Etoposide—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.32e-06	0.000241	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—EP300—uterine cancer	3.23e-06	0.000235	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	3.22e-06	0.000234	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—RRM2—uterine cancer	3.18e-06	0.000231	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AKR1C3—uterine cancer	3.18e-06	0.000231	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AKR1C3—uterine cancer	3.18e-06	0.00023	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.11e-06	0.000226	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AKR1C1—uterine cancer	3.11e-06	0.000226	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—DCN—uterine cancer	3.09e-06	0.000224	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—MTHFR—uterine cancer	3.06e-06	0.000222	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.97e-06	0.000215	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.96e-06	0.000215	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—MTHFR—uterine cancer	2.95e-06	0.000214	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP11A1—uterine cancer	2.91e-06	0.000211	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.86e-06	0.000208	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN2B—uterine cancer	2.82e-06	0.000205	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—RRM2—uterine cancer	2.77e-06	0.000201	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AKR1C3—uterine cancer	2.75e-06	0.0002	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—DCN—uterine cancer	2.69e-06	0.000195	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—POLD1—uterine cancer	2.66e-06	0.000193	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—STK11—uterine cancer	2.63e-06	0.000191	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—CYP19A1—uterine cancer	2.63e-06	0.000191	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.61e-06	0.00019	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—STAR—uterine cancer	2.61e-06	0.00019	CbGpPWpGaD
Etoposide—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.6e-06	0.000189	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—MTHFR—uterine cancer	2.59e-06	0.000188	CbGpPWpGaD
Etoposide—PTGS2—Disease—SMAD3—uterine cancer	2.57e-06	0.000187	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP11A1—uterine cancer	2.54e-06	0.000184	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—MTHFR—uterine cancer	2.49e-06	0.000181	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AKR1C1—uterine cancer	2.49e-06	0.00018	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—STK11—uterine cancer	2.48e-06	0.00018	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—CYP19A1—uterine cancer	2.48e-06	0.00018	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—CYP19A1—uterine cancer	2.47e-06	0.00018	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—STK11—uterine cancer	2.47e-06	0.00018	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.47e-06	0.000179	CbGpPWpGaD
Etoposide—PTGS2—Disease—FGFR2—uterine cancer	2.46e-06	0.000178	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.42e-06	0.000175	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AKR1C3—uterine cancer	2.4e-06	0.000174	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PIK3CA—uterine cancer	2.39e-06	0.000173	CbGpPWpGaD
Etoposide—PTGS2—Disease—MTHFR—uterine cancer	2.36e-06	0.000171	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.36e-06	0.000171	CbGpPWpGaD
Etoposide—ABCC1—Disease—ERBB2—uterine cancer	2.3e-06	0.000167	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—RRM2—uterine cancer	2.21e-06	0.000161	CbGpPWpGaD
Etoposide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.2e-06	0.000159	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—DCN—uterine cancer	2.15e-06	0.000156	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—CYP19A1—uterine cancer	2.14e-06	0.000155	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—STK11—uterine cancer	2.14e-06	0.000155	CbGpPWpGaD
Etoposide—ABCC1—Disease—CDKN1B—uterine cancer	2.13e-06	0.000154	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PTEN—uterine cancer	2.09e-06	0.000152	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—POLD1—uterine cancer	2.05e-06	0.000149	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP11A1—uterine cancer	2.03e-06	0.000147	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.01e-06	0.000146	CbGpPWpGaD
Etoposide—ABCC1—Disease—CTNNB1—uterine cancer	2.01e-06	0.000146	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—EP300—uterine cancer	2e-06	0.000145	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—MTHFR—uterine cancer	1.98e-06	0.000144	CbGpPWpGaD
Etoposide—ABCC1—Disease—PTEN—uterine cancer	1.96e-06	0.000142	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—AKT1—uterine cancer	1.95e-06	0.000142	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.92e-06	0.000139	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.92e-06	0.000139	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AKR1C3—uterine cancer	1.91e-06	0.000139	CbGpPWpGaD
Etoposide—ABCC1—Disease—EP300—uterine cancer	1.87e-06	0.000136	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—STK11—uterine cancer	1.87e-06	0.000135	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—CYP19A1—uterine cancer	1.87e-06	0.000135	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—MTHFR—uterine cancer	1.86e-06	0.000135	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—MTHFR—uterine cancer	1.86e-06	0.000135	CbGpPWpGaD
Etoposide—ABCC1—Disease—NRAS—uterine cancer	1.75e-06	0.000127	CbGpPWpGaD
Etoposide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.74e-06	0.000127	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—RRM2—uterine cancer	1.71e-06	0.000124	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PTEN—uterine cancer	1.7e-06	0.000123	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—DCN—uterine cancer	1.66e-06	0.00012	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PTEN—uterine cancer	1.64e-06	0.000119	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—EP300—uterine cancer	1.62e-06	0.000118	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—MTHFR—uterine cancer	1.61e-06	0.000117	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—EP300—uterine cancer	1.56e-06	0.000114	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.56e-06	0.000113	CbGpPWpGaD
Etoposide—PTGS2—Disease—ERBB2—uterine cancer	1.54e-06	0.000112	CbGpPWpGaD
Etoposide—ABCC1—Disease—KRAS—uterine cancer	1.5e-06	0.000109	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—CYP19A1—uterine cancer	1.49e-06	0.000108	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—STK11—uterine cancer	1.49e-06	0.000108	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PIK3CA—uterine cancer	1.48e-06	0.000107	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.48e-06	0.000107	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PTEN—uterine cancer	1.44e-06	0.000105	CbGpPWpGaD
Etoposide—PTGS2—Disease—CDKN1B—uterine cancer	1.43e-06	0.000104	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.42e-06	0.000103	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—MTHFR—uterine cancer	1.4e-06	0.000102	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.4e-06	0.000102	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PTEN—uterine cancer	1.39e-06	0.000101	CbGpPWpGaD
Etoposide—ABCC1—Disease—PIK3CA—uterine cancer	1.38e-06	0.0001	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—EP300—uterine cancer	1.38e-06	9.99e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—CTNNB1—uterine cancer	1.35e-06	9.79e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.33e-06	9.68e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—EP300—uterine cancer	1.32e-06	9.6e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PTEN—uterine cancer	1.31e-06	9.54e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—HRAS—uterine cancer	1.28e-06	9.28e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—EP300—uterine cancer	1.25e-06	9.1e-05	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—AKT1—uterine cancer	1.21e-06	8.76e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PIK3CA—uterine cancer	1.2e-06	8.71e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—NRAS—uterine cancer	1.17e-06	8.51e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PIK3CA—uterine cancer	1.16e-06	8.4e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—STK11—uterine cancer	1.15e-06	8.35e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.15e-06	8.35e-05	CbGpPWpGaD
Etoposide—ABCC1—Disease—AKT1—uterine cancer	1.13e-06	8.19e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—MTHFR—uterine cancer	1.12e-06	8.13e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PTEN—uterine cancer	1.1e-06	7.99e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—EP300—uterine cancer	1.05e-06	7.62e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PTEN—uterine cancer	1.04e-06	7.52e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PTEN—uterine cancer	1.03e-06	7.5e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PIK3CA—uterine cancer	1.02e-06	7.39e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—KRAS—uterine cancer	1.01e-06	7.32e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—EP300—uterine cancer	9.88e-07	7.17e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.87e-07	7.16e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—EP300—uterine cancer	9.86e-07	7.16e-05	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—AKT1—uterine cancer	9.81e-07	7.11e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PIK3CA—uterine cancer	9.78e-07	7.1e-05	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—AKT1—uterine cancer	9.45e-07	6.86e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—PIK3CA—uterine cancer	9.27e-07	6.73e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PTEN—uterine cancer	8.96e-07	6.5e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—MTHFR—uterine cancer	8.64e-07	6.27e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—HRAS—uterine cancer	8.58e-07	6.23e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—EP300—uterine cancer	8.54e-07	6.2e-05	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—AKT1—uterine cancer	8.32e-07	6.04e-05	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—AKT1—uterine cancer	7.99e-07	5.8e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PTEN—uterine cancer	7.8e-07	5.66e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PIK3CA—uterine cancer	7.77e-07	5.64e-05	CbGpPWpGaD
Etoposide—PTGS2—Disease—AKT1—uterine cancer	7.58e-07	5.5e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—EP300—uterine cancer	7.44e-07	5.4e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PIK3CA—uterine cancer	7.31e-07	5.31e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PIK3CA—uterine cancer	7.3e-07	5.29e-05	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—AKT1—uterine cancer	6.35e-07	4.6e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PIK3CA—uterine cancer	6.32e-07	4.59e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PTEN—uterine cancer	6.23e-07	4.52e-05	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—AKT1—uterine cancer	5.97e-07	4.33e-05	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—AKT1—uterine cancer	5.96e-07	4.33e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—EP300—uterine cancer	5.94e-07	4.31e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PIK3CA—uterine cancer	5.51e-07	4e-05	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—AKT1—uterine cancer	5.16e-07	3.75e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PTEN—uterine cancer	4.81e-07	3.49e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—EP300—uterine cancer	4.59e-07	3.33e-05	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—AKT1—uterine cancer	4.5e-07	3.26e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PIK3CA—uterine cancer	4.4e-07	3.19e-05	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—AKT1—uterine cancer	3.59e-07	2.61e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PIK3CA—uterine cancer	3.39e-07	2.46e-05	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—AKT1—uterine cancer	2.77e-07	2.01e-05	CbGpPWpGaD
